| Cameron Sinclair Olsen, DO | |
|
315 S Osteopathy Ave, Kirksville, MO 63501-6401 | |
| (801) 234-9790 | |
| Not Available |
| Full Name | Cameron Sinclair Olsen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 4 Years |
| Location | 315 S Osteopathy Ave, Kirksville, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285252973 | NPI | - | NPPES |
| 2021040341 | Other | MO | PHYSICIAN AND SURGEON LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2020018526 (Missouri) | Secondary |
| 207R00000X | Internal Medicine | 2021040341 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mark's Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Regional Hospitalists Llc | 4789807165 | 145 |
News Archive
Drivers aged over 60 have higher crash rates in non problematic operating environments -as in junctions- than drivers of other age groups. Although elderly drivers present deteriorated driving abilities, they have proved to be more cautious, to compensate such deficiencies.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Patients in rural China who received cataract surgery from specially trained non-ophthalmologists had improved vision 10 to 14 months following surgery, according to an article that will appear in the November 2007 print issue of Archives of Ophthalmology.
Drug used to treat hallucinations and delusions in Parkinson's shows promise as treatment for dementia-related psychosis (DRP).
› Verified 8 days ago
| Entity Name | Utah Regional Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962821223 PECOS PAC ID: 4789807165 Enrollment ID: O20140604000236 |
News Archive
Drivers aged over 60 have higher crash rates in non problematic operating environments -as in junctions- than drivers of other age groups. Although elderly drivers present deteriorated driving abilities, they have proved to be more cautious, to compensate such deficiencies.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Patients in rural China who received cataract surgery from specially trained non-ophthalmologists had improved vision 10 to 14 months following surgery, according to an article that will appear in the November 2007 print issue of Archives of Ophthalmology.
Drug used to treat hallucinations and delusions in Parkinson's shows promise as treatment for dementia-related psychosis (DRP).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cameron Sinclair Olsen, DO 2302 Oak Ln, Kirksville, MO 63501-2146 Ph: (801) 234-9790 | Cameron Sinclair Olsen, DO 315 S Osteopathy Ave, Kirksville, MO 63501-6401 Ph: (801) 234-9790 |
News Archive
Drivers aged over 60 have higher crash rates in non problematic operating environments -as in junctions- than drivers of other age groups. Although elderly drivers present deteriorated driving abilities, they have proved to be more cautious, to compensate such deficiencies.
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Patients in rural China who received cataract surgery from specially trained non-ophthalmologists had improved vision 10 to 14 months following surgery, according to an article that will appear in the November 2007 print issue of Archives of Ophthalmology.
Drug used to treat hallucinations and delusions in Parkinson's shows promise as treatment for dementia-related psychosis (DRP).
› Verified 8 days ago
Dr. Azhar Assadi, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. Maura Beth Gerdes, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1605 S. Baltimore St., Suite B, Kirksville, MO 63501 Phone: 660-665-3599 Fax: 660-665-7576 | |
David Vincent Spencer, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1605 S Baltimore St Ste B, Kirksville, MO 63501 Phone: 660-627-3363 Fax: 660-627-3367 | |
Dr. Stephen James Hyde, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Valena Fiscus, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-626-2223 | |
Larry R Handlin, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-785-1991 Fax: 660-785-1989 |